Gloucester Pharmaceuticals Company Profile

Aggregated data from the web about Gloucester Pharmaceuticals

Company Name	Gloucester Pharmaceuticals
Website	https://www.crunchbase.com
Snippet	Gloucester Pharmaceuticals is a biopharmaceutical company owned by Celgene that acquires clinical-stage oncology drug candidates with the goal of advancing them through regulatory approval and commercialization. Gloucester's first compound, romidepsin, is a late-stage oncology drug candidate that has shown potential activity across a range of
Type	Subsidiary
Parent	Bristol Myers Squibb
Founded	1986
Founder	Sol J. Barer
Revenue	$15.281 billion (2018)
Website	www.celgene.com
Industry	Biotechnology
Products	RevlimidAbraxanePomalyst/ImnovidThalomidIdhifa
Key people	Robert J. Hugin (Executive Chairman)Mark Alles (CEO)
Net income	$4.046 billion (2018)
Headquarters	Summit, New Jersey, U.S.
Total assets	$35.480 billion (2018)
Total equity	$6.161 billion (2018)
Number of employees	8,852 (2018)

Gloucester Pharmaceuticals is part of the United States company list

Gloucester Pharmaceuticals is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.